Emmanuel Elalouf

Emmanuel Elalouf is the current Chief Operating Officer at Pangea Biomed, and has held various positions in business and operations management at different companies over the past two decades.

Elalouf started their career in 2000 as a Business Development Manager at Eager Bio Group. Emmanuel then moved to Vascular Biogenics Ltd in 2002, where they eventually became the Executive Vice President of Strategy & Corporate Development in 2011. Elalouf left Vascular Biogenics Ltd in 2013 to join ThinkingBio Ltd, where they served as a Partner until 2017. Emmanuel then joined Pangea Therapeutics as the Chief Business Officer in 2019, and has been with the company for over two years.

Emmanuel Elalouf has an MBA from Northwestern University - Kellogg School of Management and an MBA from Tel Aviv University. Emmanuel also has a Dr from The School of Pharmacy at University Paris XI in France.

Emmanuel Elalouf works with and Ranit Aharonov - CTO. Emmanuel Elalouf reports to Tuvik Beker, CEO.